Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.57 |
| ▸ | KDR | P35968 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | PDE5A | O76074 | 2/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NAMPT | P43490 | 1/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
| ▸ | JAK3 | P52333 | 1/20 | 0.50 |
| ▸ | SYK | P43405 | 3/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | TLR4 | O00206 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29666524 | 0.89 | CYP1A2 (0.56) | KIF11KDRKMT2ANPC1RAB9A | |
| SCHEMBL14704101 | 0.89 | CYP1A2 (0.56) | KIF11KDRKMT2ANPC1RAB9A | |
| SCHEMBL17194813 | 0.88 | CYP1A2 (0.55) | KIF11KDRKMT2ANPC1RAB9A | |
| SCHEMBL26631847 | 0.85 | NPC1 (0.57) | KIF11KDRKMT2ANPC1RAB9A | |
| SCHEMBL3925320 | 0.85 | KDR (0.47) | KIF11KDRKMT2ANPC1RAB9A | |
| SCHEMBL28226643 | 0.83 | NOTUM (0.60) | KIF11KMT2AMEN1MAPTLMNA | |
| SCHEMBL4591751 | 0.82 | KMT2A (0.61) | KIF11KDRKMT2ANPC1RAB9A | |
| SCHEMBL29845262 | 0.82 | KMT2A (0.61) | KIF11KDRKMT2ANPC1RAB9A | |
| SCHEMBL29501296 | 0.82 | ALDH1A1 (0.67) | KMT2AMEN1MAPTLMNAGAA | |
| SCHEMBL3181560 | 0.82 | ALDH1A1 (0.67) | KMT2AMEN1MAPTLMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-20230111469-A1 | Organic Electronic Device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-20210376241-A1 | AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME | SFC CO., LTD. (KR) | 2021-12-02 | — | — | US | disclosed |
| US-20190140177-A1 | AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME | SFC CO., LTD. (KR) | 2019-05-09 | — | — | US | disclosed |
| WO-2008008059-A1 | ANTI-CANCER AGENTS ANS USES THEREOF | LOCUS PHARMACEUTICALS, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210376241-A1 | AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME | ARNT, SUN2, SLC7A5 | KIF11 1069/4885KDR 1396/4885KMT2A 524/4885 |
| US-20190140177-A1 | AMINE-SUBSTITUTED NAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODES INCLUDING THE SAME | ARNT, SUN2, SLC7A5 | KIF11 1069/4885KDR 1396/4885KMT2A 524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.